PremiumThe FlyCitius Pharmaceuticals and Citius Oncology announce J-Code issued for Lymphir Citius Pharmaceuticals and Citius Oncology to launch Lymphir in 1H25 Citius Oncology to explore strategic alternatives PremiumThe FlyCitius Pharmaceuticals, Citius Oncology report promising cancer trial results Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton Citius Oncology Finalizes Merger and Modifies Stock Structure 
